"The US Food and Drug Administration (FDA) is looking into the risk for serious burns and potential permanent scarring with the use of the sumatriptan iontophoretic transdermal patch (Zecuity, NuPathe Inc) for migraine, the agency said in"...
Migranal Patient Information including If I Miss a Dose
In this Article
- What is dihydroergotamine nasal (Migranal)?
- What are the possible side effects of dihydroergotamine nasal (Migranal)?
- What is the most important information I should know about dihydroergotamine nasal (Migranal)?
- What should I discuss with my healthcare provider before using dihydroergotamine nasal (Migranal)?
- How should I use dihydroergotamine nasal (Migranal)?
- What happens if I miss a dose (Migranal)?
- What happens if I overdose (Migranal)?
- What should I avoid while using dihydroergotamine nasal (Migranal)?
- What other drugs will affect dihydroergotamine nasal (Migranal)?
- Where can I get more information?
What happens if I miss a dose (Migranal)?
Since dihydroergotamine is used on an as-needed basis, you are not likely to miss a dose.
Do not use more than 6 sprays of dihydroergotamine nasal per day or more than 8 sprays per week.
What happens if I overdose (Migranal)?
Seek emergency medical attention if you think you have used too much of this medicine. An overdose of dihydroergotamine can be fatal.
Overdose can cause stomach pain, nausea, vomiting, confusion, weak or shallow breathing, numbness and tingling or pain in your hands or feet, blue-colored fingers or toes, fainting, and seizure (convulsions).
What should I avoid while using dihydroergotamine nasal (Migranal)?
Do not use dihydroergotamine nasal within 24 hours before or after using another migraine headache medicine, including:
- another ergot medicine such as ergotamine (Ergomar, Ergostat, Cafergot, Ercaf, Wigraine), ergonovine (Ergotrate), methylergonovine (Methergine), or methysergide (Sansert); or
- almotriptan (Axert), eletriptan (Relpax), frovatriptan (Frova), naratriptan (Amerge), sumatriptan (Imitrex), rizatriptan (Maxalt, Maxalt-MLT), or zolmitriptan (Zomig).
Grapefruit and grapefruit juice may interact with dihydroergotamine nasal and lead to potentially dangerous effects. Discuss the use of grapefruit products with your doctor. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
What other drugs will affect dihydroergotamine nasal (Migranal)?
Many drugs can interact with dihydroergotamine. Below is just a partial list. Talk with your doctor before using dihydroergotamine nasal if you are also taking:
- zileuton (Zyflo);
- cold or allergy medications;
- nicotine (Nicoderm, Nicorette);
- diet pills, stimulants, or medication to treat ADHD (such as Ritalin or Adderall);
- an antidepressant such as fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), nefazodone (Serzone), paroxetine (Paxil), sertraline (Zoloft), and others; or
- heart or blood pressure medication such as atenolol (Tenormin), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others.
This list is not complete and there may be other drugs that can interact with dihydroergotamine. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
Where can I get more information?
Your pharmacist can provide more information about dihydroergotamine nasal.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 2.03. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Migranal Information
- Migranal Drug Interactions Center: dihydroergotamine nasl
- Migranal Side Effects Center
- Migranal FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find the secrets to longer life.